267 related articles for article (PubMed ID: 27693185)
1. mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease.
Norambuena A; Wallrabe H; McMahon L; Silva A; Swanson E; Khan SS; Baerthlein D; Kodis E; Oddo S; Mandell JW; Bloom GS
Alzheimers Dement; 2017 Feb; 13(2):152-167. PubMed ID: 27693185
[TBL] [Abstract][Full Text] [Related]
2. mTORC2 (Rictor) in Alzheimer's Disease and Reversal of Amyloid-β Expression-Induced Insulin Resistance and Toxicity in Rat Primary Cortical Neurons.
Lee HK; Kwon B; Lemere CA; de la Monte S; Itamura K; Ha AY; Querfurth HW
J Alzheimers Dis; 2017; 56(3):1015-1036. PubMed ID: 28035937
[TBL] [Abstract][Full Text] [Related]
3. N-methyl-D-aspartate receptor-mediated calcium influx connects amyloid-β oligomers to ectopic neuronal cell cycle reentry in Alzheimer's disease.
Kodis EJ; Choi S; Swanson E; Ferreira G; Bloom GS
Alzheimers Dement; 2018 Oct; 14(10):1302-1312. PubMed ID: 30293574
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-β signals through tau to drive ectopic neuronal cell cycle re-entry in Alzheimer's disease.
Seward ME; Swanson E; Norambuena A; Reimann A; Cochran JN; Li R; Roberson ED; Bloom GS
J Cell Sci; 2013 Mar; 126(Pt 5):1278-86. PubMed ID: 23345405
[TBL] [Abstract][Full Text] [Related]
5. A novel lysosome-to-mitochondria signaling pathway disrupted by amyloid-β oligomers.
Norambuena A; Wallrabe H; Cao R; Wang DB; Silva A; Svindrych Z; Periasamy A; Hu S; Tanzi RE; Kim DY; Bloom GS
EMBO J; 2018 Nov; 37(22):. PubMed ID: 30348864
[TBL] [Abstract][Full Text] [Related]
6. Amyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.
Viola KL; Klein WL
Acta Neuropathol; 2015 Feb; 129(2):183-206. PubMed ID: 25604547
[TBL] [Abstract][Full Text] [Related]
7. Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease model.
Imamura T; Yanagihara YT; Ohyagi Y; Nakamura N; Iinuma KM; Yamasaki R; Asai H; Maeda M; Murakami K; Irie K; Kira JI
Neurobiol Dis; 2020 Apr; 137():104739. PubMed ID: 31927145
[TBL] [Abstract][Full Text] [Related]
8. Modulation of insulin signaling rescues BDNF transport defects independent of tau in amyloid-β oligomer-treated hippocampal neurons.
Takach O; Gill TB; Silverman MA
Neurobiol Aging; 2015 Mar; 36(3):1378-82. PubMed ID: 25543463
[TBL] [Abstract][Full Text] [Related]
9. Amyloid-β oligomers induce tau-independent disruption of BDNF axonal transport via calcineurin activation in cultured hippocampal neurons.
Ramser EM; Gan KJ; Decker H; Fan EY; Suzuki MM; Ferreira ST; Silverman MA
Mol Biol Cell; 2013 Aug; 24(16):2494-505. PubMed ID: 23783030
[TBL] [Abstract][Full Text] [Related]
10. SOD1 mediates lysosome-to-mitochondria communication and its dysregulation by amyloid-β oligomers.
Norambuena A; Sun X; Wallrabe H; Cao R; Sun N; Pardo E; Shivange N; Wang DB; Post LA; Ferris HA; Hu S; Periasamy A; Bloom GS
Neurobiol Dis; 2022 Jul; 169():105737. PubMed ID: 35452786
[TBL] [Abstract][Full Text] [Related]
11. Endo-lysosomal Aβ concentration and pH trigger formation of Aβ oligomers that potently induce Tau missorting.
Schützmann MP; Hasecke F; Bachmann S; Zielinski M; Hänsch S; Schröder GF; Zempel H; Hoyer W
Nat Commun; 2021 Jul; 12(1):4634. PubMed ID: 34330900
[TBL] [Abstract][Full Text] [Related]
12. Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer's Disease.
Mroczko B; Groblewska M; Litman-Zawadzka A; Kornhuber J; Lewczuk P
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954063
[TBL] [Abstract][Full Text] [Related]
13. Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease.
Ma WH; Chen AF; Xie XY; Huang YS
Neuropharmacology; 2021 Jun; 190():108342. PubMed ID: 33045243
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
Bloom GS
JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
[TBL] [Abstract][Full Text] [Related]
15. Endoplasmic reticulum stress mediates JNK-dependent IRS-1 serine phosphorylation and results in Tau hyperphosphorylation in amyloid β oligomer-treated PC12 cells and primary neurons.
Zhang X; Tang S; Zhang Q; Shao W; Han X; Wang Y; Du Y
Gene; 2016 Aug; 587(2):183-93. PubMed ID: 27185631
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of mTOR by tau in Alzheimer's disease.
Bloom GS; Norambuena A
Cytoskeleton (Hoboken); 2024 Jan; 81(1):30-34. PubMed ID: 37638691
[TBL] [Abstract][Full Text] [Related]
17. Elevating the Levels of Calcium Ions Exacerbate Alzheimer's Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau.
Guan PP; Cao LL; Wang P
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072743
[TBL] [Abstract][Full Text] [Related]
18. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
[TBL] [Abstract][Full Text] [Related]
19. Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin.
Ma QL; Yang F; Rosario ER; Ubeda OJ; Beech W; Gant DJ; Chen PP; Hudspeth B; Chen C; Zhao Y; Vinters HV; Frautschy SA; Cole GM
J Neurosci; 2009 Jul; 29(28):9078-89. PubMed ID: 19605645
[TBL] [Abstract][Full Text] [Related]
20. Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins.
Pham E; Crews L; Ubhi K; Hansen L; Adame A; Cartier A; Salmon D; Galasko D; Michael S; Savas JN; Yates JR; Glabe C; Masliah E
FEBS J; 2010 Jul; 277(14):3051-67. PubMed ID: 20573181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
